# Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/characteristics-of-a-cluster-randomized-phase-iv-human-papillomavirus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matti Lehtinen,Dan Apter,Iacopo Baussano,Tiina Eriksson,Kari Natunen,Jorma Paavonen,Simopekka Vänskä,Dan Bi,Marie‐Pierre David,Sanjoy Datta,Frank Struyf,David Jenkins,­Eero Pukkala,Geoff P. Garnett,Gary Dubin |
| Citations | 57 |
| DOI | 10.1016/j.vaccine.2014.12.019 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.vaccine.2014.12.019 |
| OpenAlex ID | https://openalex.org/W2037029396 |
| PMID | 25593103 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Dan Bi](https://scholariq.org/researchers/dan-bi/)

## Paper journal

- [Vaccine](https://scholariq.org/journals/vaccine/)

## Paper primary topic

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)

## Paper topics

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.